Moderna Inc.

About Moderna Inc.

Moderna is a biotechnology company focused on pioneering mRNA technology to deliver impactful medicines. Their mission is to create transformative mRNA medicines to improve human health and treat diseases in innovative ways.

Products & Services

mRNA Medicines:Medicines based on messenger RNA (mRNA) technology that prompt the immune system to treat or prevent diseases, offering potential for a wide range of treatments with rapid development and accessibility.

Product Pipeline:A range of development programs and clinical trials (45 programs and 36 ongoing trials) focused on mRNA-based solutions for various diseases.

Specialties

mRNA Technology Vaccine Development Clinical Trials Rapid Drug Development mRNA platform technology immune system therapeutics rapid mRNA design and production

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Investment T: - FT: Investment	A: 54300000 MR: - FA: Up to $54.3 million FAN: 54300000	D: 2025-12-18 FD: 2025-12-18	1 investors
2	RT: Debt T: - FT: Debt	A: 1500000000 MR: - FA: 1.5 billion FAN: 1500000000	D: 2025-11-20 FD: 2025-11-20	1 investors

Investment Latest

2025-12-18

$54.3M

1 investor (Pro only)

Debt 2025-11-20

$1.5B

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jagjit Ludu

Medical Affairs

K

Keke Wu

People Analytics

S

Sam Hernandez

Pathology Sciences

D

Dan Carroll

Vaccines Pipeline Commercial

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Moderna Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised